In the latest decision of the CRISPR patent wars, the US Court of Appeal of the Federal Circuit delivered its long-awaited opinion in Regents v. Broad Institute (Nos. 22-1594, 22-1653) earlier this month. However, rather than providing a clear resolution to the dispute, the Federal Circuit vacated and remanded the case, extending the already protracted battle over who first invented